<DOC>
	<DOCNO>NCT01371461</DOCNO>
	<brief_summary>Overall improvement , severity change specific clinical symptom survey outpatient depression depress state evaluate efficacy safety PAXIL tablets patient PAXIL dose increase treated constant dose .</brief_summary>
	<brief_title>Special Drug Use Investigation PAXIL Tablet ( 20mg-Clinical Symptom Progression )</brief_title>
	<detailed_description />
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Subjects 18 year Subjects diagnose depression depress state Subjects treat paroxetine prior investigation Subjects hypersensitivity paroxetine Subjects take monoamine oxidase inhibitor ( MAOIs ) within 2 week stop treatment MAOIs Concomitant use subject take pimozide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>